APOE and atherosclerosis: In apolipoprotein E (apoE)-deficient mice, inhibition of EV-mediated miR-155 transfer from SMC to endothelial cells, using anti-miR-155, reduced the endothelial injury and atherosclerosis, suggesting a promising therapy for atherosclerotic patients [161].